Table 1.
Patient characteristics | Laboratory characteristics | Genetic characteristics | Treatment | Remarks | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Sex | Age years | Hbag/dl | MCVafl |
Ferritina
μg/l |
TSATa
% |
TSAT/hepcidinb
%/nM |
TMPRSS6 variant that (probably, possibly) affects function | Oral iron[Link] | Iv iron[Link] | Other | Duration of treatment | |||
Id | IIe | IIIf | Allele 1;Allele 2 | ||||||||||||
deletion; deletion | |||||||||||||||
1 | F | 3 | 9 | 14 | 7.9 | 53 | 29 | 4.0 | 0.27 | c.del of 118 kb in 22q12.3jc.del of 118 kb in 22q12.3p.nonsense;p.nonsense | + | + | − | Iron iv age 9–14 years | |
deletion; frameshift | |||||||||||||||
2g | F | 2 | 7 | 12 | 6.8 | 54 | 53 | 5.2 | 0.48 | c.del promotor, exon 1–3;c.497delTp.nonsense;p.Leu166Argfs*37 | + | − | BloodTx | BloodTx age 2–8 years | |
frameshift; frameshift | |||||||||||||||
3 | F | 4 | 21 | 24 | 7.1 | 65 | 44 | np | 0.59 | c.497delT; c.497delT p.Leu166Argfs*37; p.Leu166Argfs*37 | + | + | Iron iv age 4–21 years | ||
4h | M | child | 31 | 33 | 10 | 63 | np | 2.8 | np | c.497delT; c.497delT p.Leu166Argfs*37; p.Leu166Argfs*37 | + | + | − | Iron iv as a child | |
5 | F | 5 | 18 | 23 | 8.1 | 61 | 16 | 2.7 | 1.0 | c.1904_1905dup; c.1904_1905dup p.Lys636Alafs*17;p.Lys636Alafs*17 | + | + | − | Iron iv at age 19 years | |
6 | F | 18 | 34 | 36 | 7.6 | 61 | 18 | 3.0 | np | c.1904_1905dup; c.1904_1905dup p.Lys636Alafs*17;p.Lys636Alafs*17 | + | + | BloodTx | Iron iv from age 34 years | Pregnant at presentation |
frameshift; nonsense | |||||||||||||||
7 | M | 0 | 6 | 9 | 5.5 | 51 | np | 4.0 | 0.53 | c.497delT; c.1832G>A p.Leu166Argfs*37; p.Trp611X | + | − | − | Iron po from age <6 years | |
frameshift; missense | |||||||||||||||
8 | F | 33 | 38 | 41 | np | np | np | np | 0.43 | c.497delT; c.1228T>C p. Leu166Argfs*37; p.Cys410Arg | + | − | Iron im | Iron im age 33–38 years | |
9 | F | 27 | 32 | 35 | 7.4 | 63 | 66 | 5.0 | 0.51 | c.497delT; c.1324G>A p.Leu166Argfs*37; p.Gly442Arg | + | + | − | Iron iv age 27–28 years | |
10 | M | 10 | 12 | 12 | 8.4 | 53 | 43 | 2.0 | 0.13 | c.497delT; c.1324G>A p.Leu166Argfs*37; p.Gly442Arg | + | + | − | Iron iv age 10–12 years | Diabetes mellitus |
11i | F | 0 | 1 | 2 | 9.8 | 66 | 16 | 4.0 | 0.78 | c.497delT; c.2383G>A p.Leu166Argfs*37; p.Val795Ile | + | − | − | Iron po from age 1 yr | |
12 | M | 2 | 3 | 8 | 6.4 | 52 | 23 | 4.0 | 0.53 | c.1904_1905dup; c.1229G>C p.Lys636Alafs*17; p.Cys410Ser | + | + | − | Iron iv from age 3 years | |
missense; missense | |||||||||||||||
13 | M | 8 | 8 | 11 | 7.9 | 56 | 9.0 | 1.9 | 0.29 | c.521T>C c.1228T>C p.Leu174Pro; p.Cys410Arg | + | − | Vitamin C |
Iron po + vitamin C from age 8 years |
|
14 | F | child | 44 | 47 | 9.3 | 66 | 34 | 3.0 | np | c.2383G>A; c.2105G>T p.Val795Ile; p.Cys702Phe | + | + |
BloodTx (child) |
Iron iv age 36–41 years |
Hypothyroidism |
Median (range) | M:F 5:9 | 4.5 (0‐33) | 7.9 (5.5–10) | 61 (51–66) | 29 (9–66) | 3.5 (1.9–5.2) | 0.51 (0.13–1.0) |